Imputing Observed Blood Pressure for Antihypertensive Treatment: Impact on Population and Genetic Analyses
Authors:
- Brinda K. RanaBRBrinda K. Rana
- Anish DhamijaADAnish Dhamija
- Matthew S. PanizzonMPMatthew S. Panizzon
- Kelly M. SpoonKSKelly M. Spoon
- Terrie VasilopoulosTVTerrie Vasilopoulos
- Carol E. FranzCFCarol E. Franz
- Michael D. GrantMGMichael D. Grant
- Kristen C. JacobsonKJKristen C. Jacobson
- Kathleen KimKKKathleen Kim
- Michael J. LyonsMLMichael J. Lyons
- Jeanne M. McCafferyJMJeanne M. McCaffery
- Phyllis K. SteinPSPhyllis K. Stein
- 14 February 2014
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Hypertension
- Vol. 27 (6) , 828-837
Abstract
Elevated blood pressure (BP), a heritable risk factor for many age-related disorders, is commonly investigated in population and genetic studies, but antihypertensive use can confound study results. Routine methods to adjust for antihypertensives may not sufficiently account for newer treatment protocols (i.e., combination or multiple drug therapy) found in contemporary cohorts. We refined an existing method to impute unmedicated BP in individuals on antihypertensives by incorporating new treatment trends. We assessed BP and antihypertensive use in male twins (n = 1,237) from the Vietnam Era Twin Study of Aging: 36% reported antihypertensive use; 52% of those treated were on multiple drugs. Estimated heritability was 0.43 (95% confidence interval (CI) = 0.20-0.50) and 0.44 (95% CI = 0.22-0.61) for measured systolic BP (SBP) and diastolic BP (DBP), respectively. We imputed BP for antihypertensives by 3 approaches: (i) addition of a fixed value of 10/5mm Hg to measured SBP/DBP; (ii) incremented addition of mm Hg to BP based on number of medications; and (iii) a refined approach adding mm Hg based on antihypertensive drug class and ethnicity. The imputations did not significantly affect estimated heritability of BP. However, use of our most refined imputation method and other methods resulted in significantly increased phenotypic correlations between BP and body mass index, a trait known to be correlated with BP. This study highlights the potential usefulness of applying a representative adjustment for medication use, such as by considering drug class, ethnicity, and the combination of drugs when assessing the relationship between BP and risk factors.Keywords
This publication has 50 references indexed in Scilit:
- Genomewide Association Study Using a High-Density Single Nucleotide Polymorphism Array and Case-Control Design Identifies a Novel Essential Hypertension Susceptibility Locus in the Promoter Region of Endothelial NO SynthaseHypertension, 2012
- Genome-Wide Profiling of Blood Pressure in Adults and ChildrenHypertension, 2012
- Combination therapy as initial treatment for newly diagnosed hypertensionAmerican Heart Journal, 2011
- A critical appraisal of the clinical effectiveness of a fixed combination of valsartan, amlodipine, and hydrochlorothiazide in achieving blood pressure goalsIntegrated Blood Pressure Control, 2011
- Genetic architecture of learning and delayed recall: A twin study of episodic memory.Neuropsychology, 2011
- Genome-wide association study of blood pressure and hypertensionNature Genetics, 2009
- QTLs of factors of the metabolic syndrome and echocardiographic phenotypes: the hypertension genetic epidemiology network studyBMC Medical Genetics, 2008
- Replication of the Wellcome Trust genome-wide association study of essential hypertension: the Family Blood Pressure ProgramEuropean Journal of Human Genetics, 2008
- Adjusting for treatment effects in studies of quantitative traits: antihypertensive therapy and systolic blood pressureStatistics in Medicine, 2005
- Inference about genetic correlationsBehavior Genetics, 1988